Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
60 seconds · no obligationView Profile
Amyotrophic lateral sclerosis is a progressive neurodegenerative disease affecting the nerve cells in the brain and spinal cord that control voluntary muscles. People typically consult a doctor when experiencing muscle twitching, limb weakness, slurred speech, or difficulty swallowing. Available therapeutic and supportive treatment options depend on a detailed specialist assessment. Compare hospitals in Turkey that treat Amyotrophic Lateral Sclerosis and get a free review of your medical records.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
NeurosurgeryVerified
English · Turkish
60 seconds · no obligationView Profile
Amyotrophic lateral sclerosis is a progressive neurodegenerative disease affecting the nerve cells in the brain and spinal cord that control voluntary muscles. People typically consult a doctor when experiencing muscle twitching, limb weakness, slurred speech, or difficulty swallowing. Available therapeutic and supportive treatment options depend on a detailed specialist assessment.
Specialty: Neurosurgery
The cost of treating Amyotrophic Lateral Sclerosis depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.
Amyotrophic Lateral Sclerosis is treated by Neurosurgery specialists. 2 clinics in Turkey on our platform offer this treatment.
Amyotrophic lateral sclerosis (ALS), often referred to as motor neurone disease (MND), is a progressive neurodegenerative condition. It affects the motor neurones—specialised nerve cells in the brain and spinal cord that transmit signals to voluntary muscles throughout the body. As these motor neurones gradually deteriorate and die, the muscles they control weaken, waste away (atrophy), and lose their ability to function.
Because voluntary muscles enable movement, speaking, swallowing, and breathing, symptoms evolve over time. The condition is often classified by where symptoms first appear:
Common clinical signs combine upper motor neurone degeneration (such as muscle stiffness, spasticity, and exaggerated reflexes) and lower motor neurone degeneration (such as visible muscle twitching known as fasciculations, severe cramps, and muscle wasting). ALS does not typically affect sensory nerves, bowel or bladder control, or eye movements in its early to moderate stages.
Diagnosing ALS requires careful evaluation because there is no single biological marker or blood test that confirms the disease. Neurologists in Turkey use established international criteria (such as the revised El Escorial or Gold Coast criteria) to confirm motor neurone degeneration and systematically exclude other treatable conditions that mimic ALS, such as cervical spondylotic myelopathy, multifocal motor neuropathy, or myasthenia gravis.
Diagnostic assessments conducted during comprehensive diagnostic workups typically include:
Patients travelling from abroad should bring comprehensive medical files, including all previous EMG tracings, DICOM discs of MRI scans, past laboratory panels, and a detailed summary from their local physician.
Currently, there is no cure for ALS. Medical management focuses on slowing functional decline, alleviating distressing symptoms, preventing complications, and maintaining quality of life. Hospital departments specialising in neurology and neurosurgical evaluations coordinate multidisciplinary care plans. Clinical decisions are always made by the treating doctor after reviewing diagnostic tests.
| Option | Typically used when | Things to know |
|---|---|---|
| Disease-Modifying Medications | Confirmed diagnosis in early to moderate stages. | Agents such as riluzole or edaravone aim to moderately slow progression. Requires monitoring of liver and renal function. |
| Respiratory Support | Respiratory muscle weakness, nocturnal hypoventilation, or drop in forced vital capacity. | Non-invasive ventilation (NIV), such as BiPAP, improves sleep quality, relieves morning headaches, and supports breathing. Managed with pulmonary specialists. |
| Nutritional Interventions | Significant dysphagia, persistent choking, or progressive weight loss. | Percutaneous endoscopic gastrostomy (PEG) tube placement, performed by gastroenterology teams, secures hydration and nutrition while bypassing swallowing difficulties. |
| Symptomatic Therapy | Muscle spasticity, painful cramps, excess saliva (sialorrhoea), or emotional lability. | Targeted medications (such as baclofen, anticholinergics, or botulinum toxin injections) reduce discomfort and oral secretions. |
| Comprehensive Rehabilitation | Mobility limitations, speech difficulties, or loss of independence in daily tasks. | Coordinated neuro-rehabilitation includes physical therapy to prevent contractures, speech therapy, and assistive communication devices. |
Pursuing an assessment or supportive intervention in Turkey requires methodical preparation. Because ALS is a progressive condition, long travel can place physical stress on the body. A structured pathway ensures patient safety and medical continuity.
Before any travel arrangements are finalised, Turkish hospital medical teams review your complete neurological records, recent imaging, and respiratory test results. This preliminary review confirms whether an international journey is clinically appropriate and outlines the necessary specialist consultations in advance.
A focused diagnostic reassessment and multidisciplinary therapy planning typically requires 5 to 7 business days. If a planned minor intervention is indicated—such as PEG tube placement or non-invasive ventilation titration—patients may need to stay 10 to 14 days to monitor recovery, ensure device tolerance, and train caregivers. Patients with mobility impairments should confirm wheelchair-accessible transport and accommodation near the clinic.
International care for ALS must integrate seamlessly with your domestic healthcare providers. Turkish specialists provide detailed bilingual medical reports, equipment prescription specifications, and therapeutic recommendations. Long-term disease monitoring, ongoing non-invasive ventilation adjustments, and end-of-life care planning must remain under the direct supervision of your local neurologist and primary care team.
International travel carries significant medical risks for patients with advanced motor neurone disease. Air travel involves reduced cabin pressure and low humidity, which can exacerbate compromised respiratory function. Patients should not travel abroad for elective medical assessment if any of the following contraindications exist:
If you experience sudden severe breathlessness, chest pain, blue discolouration of the lips or fingernails, acute confusion, or persistent choking, seek emergency medical care at your local hospital immediately rather than attempting travel.
No medical treatment currently cures Amyotrophic Lateral Sclerosis or restores dead motor neurones. Care focuses on slowing disease progression, preserving muscle function, and managing distressing symptoms. Turkish medical centres provide diagnostic clarification, medical therapies such as riluzole, and multidisciplinary supportive interventions including respiratory and nutritional support, but patients must understand that all current interventions are palliative and supportive rather than curative.
You should bring your complete neurological case history, including recent electromyography (EMG) and nerve conduction studies, MRI brain and spinal cord image discs (DICOM format), blood test panels, and baseline respiratory function tests. A formal referral or summary note from your local neurologist outlining your rate of symptom progression and current medications is essential for the medical team to evaluate your case safely.
Non-invasive ventilation (NIV), typically using a BiPAP machine, is recommended when breathing muscles weaken or sleep-disordered breathing begins. During an inpatient or outpatient assessment, pulmonologists perform overnight pulse oximetry and arterial blood gas analysis to determine optimal pressure settings. The team fits a suitable mask, monitors your comfort, and trains both you and your travelling companion on operating and maintaining the device.
A percutaneous endoscopic gastrostomy (PEG) tube is considered when swallowing difficulties cause recurrent choking, lengthy exhausting meals, dehydration, or unintended weight loss exceeding ten percent of body weight. Placing the tube before respiratory capacity drops significantly reduces procedural risks. It allows medications, fluids, and liquid nutrition to enter the stomach directly, preserving energy and nutritional status while still allowing pleasurable tasting if safely manageable.
Flying presents serious risks for individuals with advanced bulbar weakness or compromised respiratory muscles. Cabin air has reduced oxygen pressure, which can worsen hypoxaemia and carbon dioxide retention. If your forced vital capacity is below 50 percent, you require pre-flight medical clearance, continuous in-flight non-invasive ventilation, or supplemental oxygen. If you struggle to clear oral secretions or experience resting breathlessness, commercial air travel is unsafe.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.